Apitegromab Preserves Lean Mass When Combined With Tirzepatide

MONDAY, June 15, 2026-- Selective targeting of myostatin by apitegromab preserves lean mass when combined with tirzepatide, according to a study published online June 8 in Nature Medicine.Richard E. Pratley, M.D., from the AdventHealth...